Omnimed Capital, based in Texas, backs life sciences and healthtech companies at Series A and B, can lead rounds, and has a $9.43M latest fund.
1 person on the investing team, 1 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Omnimed Capital reports entry at series a, series b.
Omnimed Capital has not reported a check size.
Yes. Omnimed Capital says it can lead.
Gregory Wood (Managing Director).
No recent activity since September 2026.
Work at Omnimed Capital? Claim or correct this profile.